, Tracking Stock Market Picks
Enter Symbol:
Lev Pharmaceuticals (LEVP) [hlAlert]

down 5.35 %

Lev Pharmaceuticals (LEVP) rated Buy

Posted on: Thursday,  Jun 28, 2007  11:25 AM ET by Morgan Joseph

Morgan Joseph rated Buy Lev Pharmaceuticals (LEVP) on 06/28/2007, when the stock price was $1.68. Since then,
Lev Pharmaceuticals has lost 5.36% as of 07/22/2008's recent price of $1.59.
If you would have followed this Morgan Joseph's recommendation on LEVP, you would have lost 5.35% of your investment in 390 days.

Lev Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Lev's C1 inhibitor, proposed to be marketed as Cinryze, has been granted orphan drug status for the treatment and prevention of HAE, potentially securing, upon approval, market exclusivity for seven years. Lev has also received fast track designation status from the FDA, which facilitates the development and expedites the review of drugs and biologics intended to treat serious or life threatening conditions and that demonstrate the potential to address unmet medical needs. Lev is also evaluating the development of C1 inhibitor for the treatment of acute myocardial infarction, or heart attack, and selective other diseases and disorders in which inflammation is known or believed to play an underlying role

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/28/2007 11:25 AM Buy
1.68 3.00
as of 5/23/2009
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy